Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer

NCT04581109 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04581109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04581109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
May 27, 2021
Completion date
June 12, 2026
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer